v3 Template
I

Immunovia AB

Healthcare / Biotechnology Lund, Sweden ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$266.0M
Funding Rounds
11
Last Funding
2025-04-01

About Immunovia AB

Immunovia is dedicated to saving lives through the early detection of pancreatic cancer. Headquartered in Sweden, the company focuses on revolutionizing pancreatic cancer diagnostics, with an initial market launch in the US.

Products & Services

PancreaSure:A simple blood test designed to detect pancreatic cancer at stages 1 and 2 with high accuracy (78% detection rate in early-stage cancer and 94% specificity). It targets individuals at elevated risk due to family history or genetic mutations by detecting proteins and biomarkers of pancreatic cancer growth.

Specialties

Pancreatic Cancer Diagnostics Early Detection Technologies Blood-Based Biomarker Testing

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Warrant Exercise
T: -
FT: Warrant Exercise 		A: 1490000
MR: -
FA: approximately SEK 14.9 million
FAN: 1490000 		D: 2025-04-01
FD: 2025-04-01 		-
2 RT: Warrant Exercise
T: -
FT: Warrant Exercise 		A: 14900000
MR: -
FA: SEK 14.9 million
FAN: 14900000 		D: 2025-04-01
FD: 2025-04-01 		-
3 RT: Rights Issue
T: -
FT: Rights Issue 		A: 14900000
MR: -
FA: approximately SEK 14.9 million
FAN: 14900000 		D: 2025-03-27
FD: 2025-03-27 		-
4 RT: Warrants Exercise
T: -
FT: Warrants Exercise 		A: 14900000
MR: -
FA: approximately SEK 14.9 million
FAN: 14900000 		D: 2025-03-27
FD: 2025-03-27 		-
5 RT: Warrant Exercise
T: -
FT: Warrant Exercise 		A: 14900000
MR: -
FA: SEK 14.9 million
FAN: 14900000 		D: 2025-03-27
FD: 2025-03-27 		-
6 RT: Warrant Exercise (Series TO 2)
T: -
FT: Warrant Exercise (Series TO 2) 		A: 42400000
MR: -
FA: approximately 42.4 MSEK
FAN: 42400000 		D: 2025-01-20
FD: 2025-01-20 		-
7 RT: Warrant Exercise
T: -
FT: Warrant Exercise 		A: 4028000
MR: -
FA: approximately 42.4 MSEK
FAN: 4028000 		D: 2025-01-20
FD: 2025-01-20 		-
8 RT: Warrant Exercise
T: -
FT: Warrant Exercise 		A: 42400000
MR: -
FA: approximately 42.4 MSEK
FAN: 42400000 		D: 2025-01-20
FD: 2025-01-20 		-
9 RT: Warrant Exercise
T: -
FT: Warrant Exercise 		A: 57200000
MR: -
FA: approximately SEK 57.2 million
FAN: 57200000 		D: 2025-01-02
FD: 2025-01-02 		3 investors
10 RT: Warrant Exercise
T: -
FT: Warrant Exercise 		A: 57200000
MR: -
FA: SEK 57.2 million
FAN: 57200000 		D: 2024-12-28
FD: 2024-12-28 		3 investors
11 RT: Warrant Exercise
T: -
FT: Warrant Exercise 		A: 1651608
MR: -
FA: 1,651,608 warrants
FAN: 1651608 		D: 2024-12-18
FD: 2024-12-18 		4 investors
Warrant Exercise Latest
2025-04-01
$1.5M
Warrant Exercise 2025-04-01
$14.9M
Rights Issue 2025-03-27
$14.9M

View 10 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jeff Borcherding

Chief Executive Officer

LinkedIn (Pro only)
N

Norma Palma, PhD

VP, Clinical & Medical Affairs

LinkedIn (Pro only)
L

Lisa Ford, PhD, HCLD

Clinical Lab Director

LinkedIn (Pro only)
T

Tom King

Medical Director

P

Peter Høngaard Andersen, MD

Chair

V

Valerie Bogdan-Powers

Director

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Immunovia AB Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Biotechnology
Company Size
~150 employees (est.)
Locations
Lund, Sweden

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro